Dominion Energy receives approval to extend North Anna nuclear power station operation-March 2024-www.financetom.com

Dominion Energy receives approval to extend North Anna nuclear power station operation

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Dominion Energy receives approval to extend North Anna nuclear power station operation

Aug 30, 2024 6:28 PM

Aug 28 (Reuters) - Dominion Energy ( D ) said on

Wednesday that the Nuclear Regulatory Commission (NRC) approved

its application to extend North Anna nuclear power station's

operating licenses for an additional 20 years.

Previous page： SolarBank Acquiring Solar Flow-Through Funds In All-Stock Deal Valued At $45 Million Next page： Atlassian Insider Sold Shares Worth $1,625,502, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

SolarBank Acquiring Solar Flow-Through Funds In All-Stock Deal Valued At $45 Million

Mar 20, 2024

08:41 AM EDT, 03/20/2024 (MT Newswires) -- SolarBank Corp. (SUNN.CN), an independent renewable and clean energy project developer, said Wednesday that it agreed to acquire Solar Flow-Through Funds Ltd. (SFF) in an all-stock deal valuing SFF at up to $45 million. Under the terms, SolarBank agreed to issue up to 5,859,567 shares for up to $41.8 million or $4.50 per...

Atlassian Insider Sold Shares Worth $1,625,502, According to a Recent SEC Filing

Mar 20, 2024

08:34 AM EDT, 03/20/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on March 18, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,625,502. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 65,928 shares of the company, with 65,928 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024002804/xslF345X03/primarydocument.xml Price: 197.2, Change: +0.77,...

Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial

Mar 20, 2024

March 20 (Reuters) - Bristol Myers Squibb ( BMY ) said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating it as an initial treatment for a type of liver cancer. The results bolster the company's efforts to expand the use for the blockbuster drugs that are set to lose their market...

Market Chatter: Tesla to Raise China-Produced Model Y Price

Mar 20, 2024

08:39 AM EDT, 03/20/2024 (MT Newswires) -- Tesla (TSLA) plans to increase the price of its China-produced Model Y vehicles by 5,000 Chinese renminbi ($694.50) starting April 1, Reuters reported Wednesday, citing a confirmation from the company. Tesla did not immediately respond to MT Newswires' request for comment. (Market Chatter news is derived from conversations with market professionals globally. This...